SLC17A7 and depressive symptom measurement: This event prevented the abnormal induction of vGluT1 positive glutamatergic neurons by reducing the level of Ngn2 and then strengthened the balance between GABAergic and glutamatergic neurons after TBI, thereby improving the anxiety, depression‐like behavior, and memory function after TBI.117